Coronavirus (COVID-19) Preparedness Information Learn More
Monoclonal Antibody Treatment
UP Health System - Portage is proud to offer monoclonal antibody therapy to help treat eligible positive COVID-19 patients. Monoclonal antibody therapy helps treat non-hospitalized patients with a mild or moderate case of COVID-19.
Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful viruses. This therapy is designed to help block the COVID-19 virus and prevent the virus from further infecting healthy cells. This therapy has recieved emergency use authorization (EUA) from the Food and Drug Administration (FDA).
“Offering this treatment locally is an important step forward in helping prevent the most at-risk patients from being hospitalized due to COVID-19," said Keith Wright, DO, Internal Medicine.
Who is a candidate for monoclonal antibody treatment?
Patients must meet specific clinical criteria, including:
- Lab-confirmed COVID-19 positive test
- Stable enough to not require hospitalization
- Be within 10 days of symptom onset
In addition to meeting the above criteria, patients must also have an order from a provider to recieve this treatment. Patients receiving treatment at our hospital will be required to stay for a duration of up to 2 hours.
Who is not a candidate for this treatment?
This treatment will not be considered for patients who are currently hospitalized due to COVID-19, require oxygen therapy for COVID-19, and/or have a known hypersensitivity to the therapy.
For additional information on treatment for COVID-19 at UP Health System - Portage, please call 906.483.1574.